HomeScience › Bumetanide considered effective in the...

Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026? — Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?

14.0%
Probability on Futuur

On Futuur, "Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026? — Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?" has a probability of 14.0%. Trading volume: $637.

View on Futuur →
Probability Over Time
Market Details
Futuur
Updated 3h ago
Volume
$637
Volume 24h
Liquidity
Traders
27 traders
Bid / Ask
— / —
Spread
Opened
Apr 2026
Resolves
Dec 2026

Single Platform Data

This question is currently tracked on Futuur only. When the same question appears on additional platforms, we compute a cross-platform consensus probability. Learn about our methodology →

Odds Raven

The only prediction market aggregator with academically validated cross-platform consensus.

© 2026 Odds Raven · Data refreshed every 6 hours · peer-reviewed methodology